跳至主要内容
临床试验/KCT0004728
KCT0004728招募中未知

sefulness of acellular dermal matrix (Megaderm®) in breast cancer surgery

Myongji Hospital0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
Female

入选标准

  • (1) Female patients aged =19 years
  • (2) Subjects to treat partial mastectomy or radical surgery of breast and axilla for diagnosis of breast cancer
  • (3) Patients with breast cancer in stages 0-3
  • (4) Subjects who needed the using the Megaderm® before primary suture immediately after surgery.
  • (5) Subject who can follow-up investigation

排除标准

  • (1) 4th stage metastatic or inflammatory breast cancer patient
  • (2) Patients with infectious diseases, autoimmune disease, and hemostatic disorder
  • (3) Patients suspected of inflammatory infection in the breast before surgery
  • (4) Pregnancy
  • (5) Other, subjects deemed to be in difficulty with clinical research or not required to use Megaderm® by the judgment of the investigator

研究者

相似试验

sefulness of acellular dermal matrix (Megaderm®) in... | 临床试验